IP Verse

Combination Immunotherapy For The Treatment Of Cancer - EP2482849B1

PatentPatent Analysis

EP2482849

BOARD OF REGENTS
Application Number
EP10821297A
Filing Date
Sep 30, 2010
Status
Revoked
May 8, 2023
Grant Date
Jun 6, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3092636B1
EP2997134B1
EP2855707B1

Bibliography

The patent EP2482849B1 was granted to Board OF Regents on Jun 6, 2018 following the initial filing on Sep 30, 2010 under the application number EP10821297A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXOSMITHKLINEMar 6, 2019 -
KYMABMar 6, 2019 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents